Codexis to Participate in Jefferies Global Healthcare Conference

Argan (NYSE: AGX) has appointed Lisa Larroque Alexander to its Board of Directors.

Rhea-AI Summary

Argan (NYSE: AGX) has appointed Lisa Larroque Alexander to its Board of Directors. Alexander currently serves as Senior Vice President at Sempra (NYSE: SRE), a major energy infrastructure company with a $43 billion market capitalization and 22,000 employees. At Sempra, she leads global corporate affairs and enterprise human resources, managing public policy, stakeholder engagement, talent development, pensions and trusts, corporate ethics, sustainability, and HR. Her extensive experience includes leadership roles in strategy, R&D, public policy, industrial customer operations, and service delivery. The appointment brings valuable energy sector expertise to Argan's board.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

REDWOOD CITY, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the Jefferies Global Healthcare Conference, being held June 3-5, 2025, in New York, New York.

Management will participate in a fireside chat on Wednesday, June 4, 2025, at 3:10 pm ET. A live webcast of the event will be available in the Investor Relations section of the Company’s website, https://ir.codexis.com. A replay will be archived for 90 days following the event.

About Codexis

Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, leveraging its proprietary CodeEvolver^® technology platform to discover, develop and enhance novel, high-performance enzymes. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.

For More Information

Investor Contact
Carrie McKim
(336) 608-9706
ir@codexis.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is Lisa Larroque Alexander and what is her role at Sempra (SRE)?

Lisa Larroque Alexander is Senior Vice President at Sempra, leading global corporate affairs and enterprise human resources. She oversees public policy, stakeholder engagement, talent development, pensions and trusts, corporate ethics, sustainability, and HR at the $43 billion energy infrastructure company.

Why did Argan (AGX) appoint Lisa Alexander to its Board of Directors?

Argan appointed Lisa Alexander for her extensive expertise in the energy sector and corporate experience. Her background in strategy, R&D, public policy, and operations at Sempra will contribute valuable perspectives to Argan's growth and expansion plans.

What is Sempra's (SRE) current market size and workforce?

Sempra is an energy infrastructure company with a $43 billion market capitalization and employs approximately 22,000 people.

What are Lisa Alexander's areas of expertise at Sempra (SRE)?

Lisa Alexander's expertise includes leadership in strategy, research and development, public policy, industrial customer operations, service delivery, global corporate affairs, and enterprise human resources management.